Are Arvee Laboratories (India) Ltd latest results good or bad?
2026-05-20 19:24:34Arvee Laboratories (India) Ltd's latest financial results for Q4 FY26 present a complex picture of operational performance. The company reported a net profit of ₹0.52 crores, which reflects a significant year-on-year growth of 642.86% compared to the same quarter last year. However, this figure represents a notable decline of 71.58% on a quarter-on-quarter basis, indicating volatility in profitability. Revenue for the same quarter reached ₹10.80 crores, marking a quarter-on-quarter increase of 10.43% and a year-on-year growth of 67.44%. This revenue growth is positive, yet it is accompanied by concerns regarding the sustainability of such performance, as the company has faced dramatic fluctuations in revenue throughout the fiscal year. Operating margins have also come under pressure, with the operating margin dropping to 10.19% from 16.56% in the previous quarter, and the PAT margin declining to 4.81% fro...
Read full news article
Arvee Laboratories (India) Ltd is Rated Strong Sell
2026-05-20 10:10:37Arvee Laboratories (India) Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 24 February 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 20 May 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news article
Arvee Laboratories Reports Positive Financial Turnaround in Q4 2026
2026-05-20 08:00:21Arvee Laboratories (India) Ltd, a micro-cap player in the Chemicals & Petrochemicals sector, has demonstrated a notable improvement in its financial performance for the quarter ended March 2026. The company’s financial trend has shifted from flat to positive, with significant growth in net sales and profit after tax (PAT), signalling a potential turnaround amid a challenging market environment.
Read full news article
Arvee Laboratories Q4 FY26: Profit Recovery Masks Persistent Margin Weakness
2026-05-19 22:17:26Arvee Laboratories (India) Ltd., a micro-cap specialised chemicals manufacturer with a market capitalisation of ₹174.00 crores, reported a sequential recovery in profitability for Q4 FY26, though the numbers reveal concerning underlying trends that continue to plague the Ahmedabad-based company. Net profit stood at ₹0.52 crores for the March quarter, marking a sharp 71.58% decline from the exceptional ₹1.83 crores reported in Q3 FY26, but representing a substantial 642.86% year-on-year improvement from the mere ₹0.07 crores in Q4 FY25.
Read full news article
Arvee Laboratories Locks at Lower Circuit With 10% Loss — Sellers Queue, No Buyers in Sight
2026-05-18 10:00:33At Rs 147.15, sellers were still queuing — but there were no buyers willing to take the other side. Arvee Laboratories (India) Ltd locked at its lower circuit of 10% on 18 May 2026, with unfilled sell orders and a frozen price.
Read full news article
Arvee Laboratories (India) Ltd is Rated Strong Sell
2026-05-09 10:10:14Arvee Laboratories (India) Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 24 Feb 2026, reflecting a shift from the previous 'Sell' grade. However, the analysis and financial metrics discussed here represent the stock's current position as of 09 May 2026, providing investors with an up-to-date perspective on the company’s fundamentals and market performance.
Read full news article
Arvee Laboratories (India) Ltd is Rated Strong Sell
2026-04-28 10:10:03Arvee Laboratories (India) Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 24 February 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 28 April 2026, providing investors with the most recent and relevant data to assess the company’s outlook.
Read full news article
Arvee Laboratories (India) Ltd is Rated Strong Sell
2026-04-17 10:10:03Arvee Laboratories (India) Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 24 February 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 17 April 2026, providing investors with the latest insights into its performance and outlook.
Read full news article
Arvee Laboratories Locks at Upper Circuit With 6.28% Gain — Buyers Queue, Sellers Absent
2026-04-10 10:00:41At Rs 186.19, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Arvee Laboratories (India) Ltd locked at its upper circuit of 6.28% on 10 Apr 2026, with buyers queuing and no sellers willing to part with shares.
Read full news articleArvee Laboratories (India) Limited - Clarification - Financial Results
03-Dec-2019 | Source : NSEArvee Laboratories (India) Limitedies (India) Limited for the quarter ended 30-Sep-2019 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Arvee Laboratories (India) Limited - Outcome of Board Meeting
14-Nov-2019 | Source : NSEArvee Laboratories (India) Limited has informed the Exchange regarding Board meeting held on November 14, 2019.
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
Arvee Laboratories (India) Ltd has announced 1:1 bonus issue, ex-date: 13 Oct 20
No Rights history available






